Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

168 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q1 2019.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 101,633,429 shares of 315,976,000 outstanding shares and own 32.16% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (19,861,418 shares), Fosun International Ltd (19,552,001 shares), WELLINGTON MANAGEMENT GROUP LLP (15,907,280 shares), VANGUARD GROUP INC (9,539,131 shares), BlackRock Inc. (5,845,706 shares), TPG Group Holdings (SBS) Advisors, Inc. (3,884,600 shares), JANUS HENDERSON GROUP PLC (2,382,283 shares), TCW GROUP INC (2,302,363 shares), STATE STREET CORP (1,940,492 shares), and AMERIPRISE FINANCIAL INC (1,826,285 shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.